semaglutide tinnitus case report Ototoxic drugs & risk of ✓ Risk of Hearing Loss in – semaglutide tinnitus case report Lenire

You tell us your current medication, the dose you're on, and how long you've been on it

Your prescribing clinicianwhether a GP, diabetes specialist nurse, or consultantshould provide guidance on recognising concerning symptoms and when to seek advice

This reluctance is likely to be at least partially attributable to the fact that, until recently, all GLP-1RAs were available as subcutaneous (s.c.) injections, given twice daily (exenatide [13]), once daily (lixisenatide [14] and liraglutide [15]), or once weekly (semaglutide [16], dulaglutide [17], and exenatide extended release [18]), a route that may be less preferable to some patients compared with oral administration [1, 19]

Table 1 offers a small recap of the current evidence of the benefits derived from natural compounds, both on vitiligo and on MH disorders